These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 14555546)

  • 1. Dosing inhaled steroids in asthma: is once-a-day administration effective?
    Marcus P
    Chest; 2003 Oct; 124(4):1196-8. PubMed ID: 14555546
    [No Abstract]   [Full Text] [Related]  

  • 2. Reducing inhaled corticosteroids in asthma is just the start.
    Weiner JM
    Med J Aust; 2003 Aug; 179(3):173. PubMed ID: 12885275
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhaled corticosteroids and adrenal insufficiency.
    Russell G
    Arch Dis Child; 2002 Dec; 87(6):455-6. PubMed ID: 12456537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenal suppression related to inhaled corticosteroids revisited.
    Caballero-Fonseca F; Sánchez-Borges M
    Chest; 2002 Sep; 122(3):1103-4; author reply 1104. PubMed ID: 12226066
    [No Abstract]   [Full Text] [Related]  

  • 5. Reducing asthma treatment.
    Chen R
    N Engl J Med; 2007 Aug; 357(5):504; author reply 505-6. PubMed ID: 17674455
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy and safety of once-daily fluticasone furoate/vilanterol (FF/VI) versus twice-daily inhaled corticosteroids/long-acting β
    Devillier P; Humbert M; Boye A; Zachgo W; Jacques L; Nunn C; West S; Nicholls A; Antoun Z; Spinu L; Grouin JM
    Respir Med; 2018 Aug; 141():111-120. PubMed ID: 30053956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ciclesonide (Alvesco)-a new inhaled corticosteroid for asthma.
    Med Lett Drugs Ther; 2008 Sep; 50(1295):75-6. PubMed ID: 18800024
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhaled fluticasone propionate by diskus in the treatment of asthma: a comparison of the efficacy of the same nominal dose given either once or twice a day.
    Purucker ME; Rosebraugh CJ; Zhou F; Meyer RJ
    Chest; 2003 Oct; 124(4):1584-93. PubMed ID: 14555594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Once-daily fluticasone furoate is efficacious in patients with symptomatic asthma on low-dose inhaled corticosteroids.
    Bleecker ER; Bateman ED; Busse WW; Woodcock A; Frith L; House KW; Jacques L; Davis AM; Haumann B; Lötvall J
    Ann Allergy Asthma Immunol; 2012 Nov; 109(5):353-358.e4. PubMed ID: 23062392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of inhaled corticosteroids in smokers/ex-smokers and nonsmokers with asthma.
    Roche N; Postma DS; Colice G; Burden A; Guilbert TW; Israel E; Martin RJ; van Aalderen WM; Grigg J; Hillyer EV; von Ziegenweidt J; Price DB
    Am J Respir Crit Care Med; 2015 Apr; 191(8):960-4. PubMed ID: 25876207
    [No Abstract]   [Full Text] [Related]  

  • 11. Combination inhalers containing inhaled corticosteroids and long-acting beta2-agonists: improved clinical efficacy and dosing options in patients with asthma.
    Ankerst J
    J Asthma; 2005 Nov; 42(9):715-24. PubMed ID: 16316864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticosteroids in the emergency treatment of acute severe asthma.
    Lim TK
    Chest; 2000 May; 117(5):1526-7. PubMed ID: 10807855
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and safety comparison: Fluticasone furoate and fluticasone propionate, after step down from fluticasone furoate/vilanterol in Japanese patients with well-controlled asthma, a randomized trial.
    Adachi M; Goldfrad C; Jacques L; Nishimura Y
    Respir Med; 2016 Nov; 120():78-86. PubMed ID: 27817819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steroid sparing effects of intranasal corticosteroids in asthma and allergic rhinitis.
    Nair A; Vaidyanathan S; Clearie K; Williamson P; Meldrum K; Lipworth BJ
    Allergy; 2010 Mar; 65(3):359-67. PubMed ID: 19804441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing asthma treatment.
    Zitt MJ; Rachelefsky GS
    N Engl J Med; 2007 Aug; 357(5):504-5; author reply 505-6. PubMed ID: 17674454
    [No Abstract]   [Full Text] [Related]  

  • 16. Spotlight on fluticasone furoate/vilanterol trifenatate for the once-daily treatment of asthma: design, development and place in therapy.
    Albertson TE; Bullick SW; Schivo M; Sutter ME
    Drug Des Devel Ther; 2016; 10():4047-4060. PubMed ID: 28008228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled steroids and asthma.
    Blaiss MS
    Pediatrics; 2002 Nov; 110(5):1030-1; author reply 1030-1. PubMed ID: 12415050
    [No Abstract]   [Full Text] [Related]  

  • 18. Moderate dose inhaled corticosteroid-induced symptomatic adrenal suppression: case report and review of the literature.
    Schwartz RH; Neacsu O; Ascher DP; Alpan O
    Clin Pediatr (Phila); 2012 Dec; 51(12):1184-90. PubMed ID: 23043135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term efficacy and safety of fluticasone propionate powder administered once or twice daily via inhaler to patients with moderate asthma.
    ZuWallack R; Adelglass J; Clifford DP; Duke SP; Wire PD; Faris M; Harding SM
    Chest; 2000 Aug; 118(2):303-12. PubMed ID: 10936117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenal suppression with cushingoid features from inhaled corticosteroid therapy in an adult asthmatic patient.
    Tsoukas MA; Krishnamoorthy P; Richards BJ; Pepe C; Christopoulos S
    Am J Med; 2014 May; 127(5):e1-2. PubMed ID: 24412770
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.